Form 4: Oaktree Acquisition Corp. III Life Sciences: Major Shareholder Activity Following Underwriters' Over-Allotment Option

Oaktree Acquisition Holdings III LS, LLC reports changes in beneficial ownership of Oaktree Acquisition Corp. III Life Sciences shares following the partial exercise of the underwriters' over-allotment option.

Summary

• Oaktree Acquisition Holdings III LS, LLC filed a Form 4 detailing changes in beneficial ownership of Oaktree Acquisition Corp. III Life Sciences shares.
• The filing is related to the partial exercise of the over-allotment option by the underwriters of the issuer's initial public offering on October 30, 2024.
• Oaktree Acquisition Holdings III, LLC purchased 33,981 additional private placement units at $10.00 per unit.
• These units consist of Class A ordinary shares and warrants.
• Oaktree Acquisition Holdings III, LLC also forfeited 231,492 Class B ordinary shares at no cost due to the partial exercise of the over-allotment option.
• Following the reported transactions, Oaktree Acquisition Holdings III, LLC beneficially owns 583,981 Class A ordinary shares directly.
• Oaktree Acquisition Holdings III, LLC also holds 116,796 private placement warrants and has an obligation to purchase Class A ordinary shares and private placement warrants.
• The filing involves multiple reporting persons, including Oaktree entities, Brookfield entities, and BAM Partners Trust, all disclaiming beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: The document primarily reflects routine transactions following an IPO. The forfeiture of shares is a neutral event, and the purchase of additional units is a slightly positive sign of continued investment.

Negatives

• Oaktree Acquisition Holdings III, LLC forfeited 231,492 Class B ordinary shares, although this was at no cost.

Future Outlook

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the issuer's initial business combination.

Industry Context

This filing is typical for special purpose acquisition companies (SPACs) following their initial public offering and the exercise of over-allotment options by underwriters. It reflects adjustments in ownership structure and the distribution of securities.

Comparison to Industry Standards

• SPACs like Oaktree Acquisition Corp. III Life Sciences often issue founder shares (Class B) and private placement units to sponsors and related parties.
• The conversion of Class B shares to Class A shares upon a business combination is a standard feature in SPAC structures.
• The forfeiture of shares due to partial exercise of over-allotment options is also a common occurrence in SPAC IPOs.
• Comparable companies include other SPACs in the life sciences sector, such as CM Life Sciences III Inc. and Decibel Therapeutics, which have similar ownership structures and transaction patterns.

Related Party Transactions

• The purchase of private placement units by Oaktree Acquisition Holdings III, LLC is a related party transaction.

Stakeholder Impact

• The transactions affect the ownership structure of the company, potentially impacting shareholders.
• The conversion of Class B shares to Class A shares will dilute the ownership of existing Class A shareholders.

Next Steps

• The issuer will seek an initial business combination, at which point the Class B ordinary shares will convert into Class A ordinary shares.

Key Dates